Claind, an Italian company founded in 1979 and specializing in hydrogen generators for laboratories, is proud to be a partner in the European AEMELIA project. This initiative, funded with €2.764 million under the HORIZON-JTI-CLEANH2-2023-1 program, will run from 2024 to 2027. Its mission is to develop anion exchange membrane electrolyzers (AEMELs) that exceed Hydrogen Europe’s 2030 targets in performance, durability, safety, and cost.
The primary goal of AEMELIA is to design and prototype electrolyzers achieving high current density (1.5 A/cm²) and low operating voltage (1.75 V), significantly enhancing energy efficiency beyond 2030 benchmarks. The project focuses on innovative materials, such as fluorine-free ionomers, thin high-conductivity membranes, platinum group metal-free catalysts, and ionomer-free electrodes. These advancements leverage abundant, safe materials that can be scaled using existing production processes.
Claind will contribute its expertise in compact hydrogen generator production and the development of AEM stacks and PEM catalysts, collaborating with research centers and international partners. With a strong presence in the chemical, pharmaceutical, and food industries, Claind’s participation in AEMELIA underscores its commitment to innovation and sustainable hydrogen production technologies.
The AEMELIA consortium brings together leading research and industry partners, including SINTEF (Norway), IC2MP (France), CEA/Liten (France), Matgenix (Belgium), Syensqo (Belgium), CNR-ITAE (Italy), TECNALIA (Spain), and Imperial College London (UK). Together, they aim to develop groundbreaking solutions to accelerate the transition to hydrogen as a key energy carrier.
For more information about the AEMELIA project and Claind’s role, visit the official project website:
